Is Avalyn Pharma Inc. Common Stock (AVLN) a Buy, Sell, or Hold?
NASDAQ : AVLN
Avalyn Pharma Inc. Common Stock — Analyst Ratings
$29.03 USD
$0.4 (1.4%)
- Volume
- 292.21K
- Average Volume
- 519.64K
- Market Capitalization
- $1.29B
- P/E Ratio
- -14.23
- Dividend Yield
- 0.00%
- Price Target
- $52.50
- Year High
- $33.32
- Year Low
- $24.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.19
Analyst Consensus Summary
Consensus Rating
Sell
0 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-44.7%
vs Current Price
Price Target
$52.50
Average TargetPrice Target Range
Lowest Target
$51.00
-43.1% DOWNSIDE
Average Target
$52.50
Median Estimate
Highest Target
$80.00
-63.7% DOWNSIDEAnalyst Breakdown
Overall Consensus: N/A | Total Analysts: 0
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Evercore ISI | Gavin Clark-Gartner | $51 | $28.41 | 2026-05-26 08:41 AM | 79.5% |